In fact, the number of activated or effector T cells did demonstrate a decreasing trend in patients with advanced stage GC, which was accompanied by an elevation of IL-35-producing B cells.
1
—
—
In fact, the number of activated or effector T cells did demonstrate a decreasing trend in patients with advanced stage GC, which was accompanied by an elevation of IL-35-producing B cells.